Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats

International Journal of Neuropsychopharmacology

Volumn 15, Issue 7, 2012, Pages 919-929

  Reichel, Carmela M ^a   See, Ronald E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Abstinence; methamphetamine; modafinil; reinstatement; relapse

Indexed keywords

METHAMPHETAMINE; MODAFINIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EXPOSURE; DRUG MEGADOSE; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE;

ANALYSIS OF VARIANCE; ANIMALS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG-SEEKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; MALE; METHAMPHETAMINE; RATS; RATS, LONG-EVANS; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TIME FACTORS;

EID: 84864366578     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000988     Document Type: Article

References (64)

1. Bernardi RE, Lewis JR, Lattal KM, Berger SP (2009). Modafinil reinstates a cocaine conditioned place preference following extinction in rats. Behavior Brain Research 204, 250-253.
2. Bouton ME (2002). Context, ambiguity, and unlearning : sources of relapse after behavioral extinction. Biological Psychiatry 52, 976-986. (Pubitemid 35356355)
3. Childress AR, Hole AV, Ehrman RN, Robbins SJ, et al. (1993). Cue reactivity and cue reactivity interventions in drug dependence. National Institute of Drug Abuse Reseach Monograph 137, 73-95.
4. Conklin CA (2006). Environments as cues to smoke: implications for human extinction-based research and treatment. Experimental and Clinical Psychopharmacology 14, 12-19.
5. Cornish JL, Kalivas PW (2000). Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. Journal of Neuroscience 20, RC89.
6. Dackis CA, Lynch KG, Yu E, Samaha FF, et al. (2003). Modafinil and cocaine : a double-blind, placebo-controlled drug interaction study. Drug and Alcohol Dependence 70, 29-37. (Pubitemid 36385151)
7. Davis M, Ressler K, Rothbaum BO, Richardson R (2006). Effects of D-cycloserine on extinction : translation from preclinical to clinical work. Biological Psychiatry 60, 369-375. (Pubitemid 44215855)
8. De La Garza R, Zorick T, London E, Newton T (2009). Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug and Alcohol Dependence 106, 173-180.
9. Deroche-Gamonet V, Darnaudéry M, Bruins-Slot L, Piat F, et al. (2002). Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology 161, 387-395. (Pubitemid 34595790)
10. Dopheide MM, Morgan RE, Rodvelt KR, Schachtman TR, et al. (2007). Modafinil evokes striatal 3Hdopamine release and alters the subjective properties of stimulants. European Journal of Pharmacology 568, 112-123. (Pubitemid 46976895)
11. Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, et al. (1998). The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat : evidence for a preferential inhibition of striato-pallidal GABA transmission. Neuroscience Letters 253, 135-138. (Pubitemid 28430641)
12. Fuchs RA, Branham RK, See RE (2006). Different neural substrates mediate cocaine seeking after abstinence vs. extinction training : a critical role for the dorsolateral caudate-putamen. Journal of Neuroscience 26, 3584-3588.
13. Gasior M, Witkin JM, Goldberg SR, Munzar P (2004). Chlormethiazole potentiates the discriminative stimulus effects of methamphetamine in rats. European Journal of Pharmacology 494, 183-189. (Pubitemid 38798103)
14. Gatch MB, Selvig M, Forster MJ (2005). GABAergic modulation of the discriminative stimulus effects of methamphetamine. Behavioural Pharmacology 16, 261-266. (Pubitemid 40943900)
15. Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, et al. (2011). Effect of modafinil on learning and task-related brain activity in methamphetaminedependent and healthy individuals. Neuropsychopharmacology 36, 950-959.
16. Gold LH, Balster RL (1996). Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology 126, 286-292. (Pubitemid 26276699)
17. Grimm JW, Hope BT, Wise RA, Shaham Y (2001). Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412, 141-142.
18. Heinzerling KG, Swanson A-N, Kim S, Cederblom L, et al. (2010). Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence 109, 20-29.
19. Hill T, Lewicki P (2007) Statistics Methods and Application. Tulsa : StatSoft.
20. Kalechstein AD, De La Garza R, Newton TF (2010). Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. American Journal of Addiction 19, 340-344.
21. Kalivas PW (2009). The glutamate homeostasis hypothesis of addiction. Nature Reviews Neuroscience 10, 561-572.
22. Karila L, Weinstein A, Aubin H-J, Benyamina A, et al. (2010). Pharmacological approaches to methamphetamine dependence: a focused review. British Journal of Clinical Pharmacology 69, 578-592.
23. Keating GM, Raffin MJ (2005). Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. Central Nervous System Drugs 19, 785-803. (Pubitemid 41327371)
24. Knackstedt LA, Moussawi K, Lalumiere R, Schwendt M, et al. (2010). Extinction training after cocaine selfadministration induces glutamatergic plasticity to inhibit cocaine seeking. Journal of Neuroscience 30, 7984-7992.
25. Lee J-H, Kwon H, Choi J, Yang B-H (2007). Cue-exposure therapy to decrease alcohol craving in virtual environment. Cyberpsychology and Behavior 10, 617-623. (Pubitemid 47573892)
26. Ling W, Rawson R, Shoptaw S, LingW (2006). Management of methamphetamine abuse and dependence. Current Psychiatry Report 8, 345-354. (Pubitemid 44515386)
27. Madras BK, Xie Z, Lin Z, Jassen A, et al. (2006). Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. Journal of Pharmacology and Experimental Therapeutics 319, 561-569.
28. Malcolm R, Book S, Moak D, Devane L, et al. (2002). Clinical applications of modafinil in stimulant abusers: low abuse potential. American Journal of Addiction 11, 247-249. (Pubitemid 34856441)
29. Marissen MAE, Franken IHA, Blanken P, van den Brink W, et al. (2007). Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial. Psychotherapy and Psychosomatics 76, 97-105. (Pubitemid 46145638)
30. McGaugh J, Mancino MJ, Feldman Z, Chopra MP, et al. (2009). Open-label pilot study of modafinil for methamphetamine dependence. Journal of Clinical Psychopharmacology 29, 488-491.
31. Mignot E, Nishino S, Guilleminault C, Dement WC (1994). Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17, 436-437. (Pubitemid 24271517)
32. Minzenberg MJ, Carter CS (2008). Modafinil : a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33, 1477-1502. (Pubitemid 351684703)
33. Munzar P, Goldberg SR (1999). Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 143, 293-301. (Pubitemid 29204984)
34. Munzar P, Goldberg SR (2000). Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 148, 209-216. (Pubitemid 30104144)
35. Munzar P, Laufert MD, Kutkat SW, Nováková J, et al. (1999). Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. Journal of Pharmacology and Experimental Therapeutics 291, 239-250. (Pubitemid 29451596)
36. Munzar P, Tanda G, Justinova Z, Goldberg SR (2004). Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29, 705-717. (Pubitemid 38402478)
37. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, et al. (2000). Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. Journal of Neuroscience 20, 798-805. (Pubitemid 30225582)
38. Newman JL, Negus SS, Lozama A, Prisinzano TE, et al. (2010). Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys. Experimental and Clinical Psychopharmacology 18, 395-408.
39. O'Brien C (2006) Drug addiction and drug abuse. In : Brunton LL, Lazo J, Parker KL (Eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics (pp. 607-627). New York: McGraw-Hill.
40. Otto MW, Safren SA, Pollack MH (2004). Internal cue exposure and the treatment of substance use disorders : lessons from the treatment of panic disorder. Journal of Anxiety Disorders 18, 69-87. (Pubitemid 38058791)
41. Paterson NE, Fedolak A, Olivier B, Hanania T, et al. (2010). Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents. Pharmacology Biochemistry and Behavior 95, 449-456.
42. Quirk GJ, Mueller D (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56-72. (Pubitemid 350191313)
43. Reichel CM, Bevins RA (2009). Forced abstinence model of relapse to study pharmacological treatments of substance use disorder. Current Drug Abuse Reviews 2, 184-194.
44. Reichel CM, Moussawi K, Do PH, Kalivas PW, et al. (2011). Chronic N-acetylcysteine during abstinence or extinction following cocaine self-administration produces enduring reductions in drug-seeking. Journal of Pharmacology and Experimental Therapeutics 337, 487-493.
45. Reichel CM, See RE (2010). Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse. Psychopharmacology 210, 337-346.
46. Reichel CM, Wilkinson JL, Bevins RA (2007). Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task. Behavioural Pharmacology 18, 755-765. (Pubitemid 350076432)
47. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, et al. (2004). Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 61, 1136-1144. (Pubitemid 39463415)
48. Rose ME, Grant JE (2008). Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Annals of Clinical Psychiatry 20, 145-155. (Pubitemid 352009285)
49. Rush CR, Kelly TH, Hays LR, Wooten AF (2002). Discriminative-stimulus effects of modafinil in cocainetrained humans. Drug and Alcohol Dependence 67, 311-322. (Pubitemid 34786266)
50. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, et al. (2007). Attentional control and brain metabolite levels in methamphetamine abusers. Biological Psychiatry 61, 1272-1280. (Pubitemid 46726259)
51. Schmidt EF, Sutton MA, Schad CA, Karanian DA, et al. (2001). Extinction training regulates tyrosine hydroxylase during withdrawal from cocaine self-administration. Journal of Neuroscience 21, RC137.
52. Schwendt M, Rocha A, See R, Pacchioni A, et al. (2009). Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. Journal of Pharmacology and Experimental Therapeutics 331, 555.
53. Self DW (2004). Regulation of drug-taking and-seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47 (Suppl. 1), 242-255. (Pubitemid 39298268)
54. Shaham Y, Shalev U, Lu L, De Wit H, et al. (2003). The reinstatement model of drug relapse : history, methodology and major findings. Psychopharmacology 168, 3-20. (Pubitemid 36851158)
55. Shearer J, Darke S, Rodgers C, Slade T, et al. (2009). A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction 104, 224-233.
56. Sutton MA, Schmidt EF, Choi K-H, Schad CA, et al. (2003). Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 421, 70-75. (Pubitemid 36077086)
57. Tahsili-Fahadan P, Carr GV, Harris GC, Aston-Jones G (2010). Modafinil blocks reinstatement of extinguished opiate-seeking in rats : mediation by a glutamate mechanism. Neuropsychopharmacology 35, 2203-2210.
58. van Vliet SAM, van Vlieta SAM, Blezer ELA, Jongsma MJ, et al. (2008). Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy. Brain Research 1189, 219-228.
59. Vocci FJ, Appel NM (2007). Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 102 (Suppl. 1), 96-106. (Pubitemid 46328210)
60. Volkow ND, Fowler JS, Logan J, Alexoff D, et al. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain : clinical implications. Journal of the American Medical Association 301, 1148-1154.
61. Vosburg SK, Hart CL, Haney M, Rubin E, et al. (2009). Modafinil does not serve as a reinforcer in cocaine abusers. Drug and Alcohol Dependence 106, 233-236.
62. Yahyavi-Firouz-Abadi N, See RE (2009). Anti-relapse medications : preclinical models for drug addiction treatment. Pharmacology & Therapeutics 124, 235-247.
63. Zavala AR, Biswas S, Harlan RE, Neisewander JL (2007). Fos and glutamate AMPA receptor subunit coexpression associated with cue-elicited cocaine-seeking behavior in abstinent rats. Neuroscience 145, 438-452. (Pubitemid 46341664)
64. Zolkowska D, Jain R, Rothman RB, Partilla JS, et al. (2009). Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. Journal of Pharmacology and Experimental Therapeutics 329, 738-746.